232 related articles for article (PubMed ID: 24698716)
1. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
Sagüés M; Paredes V; Altés J; Fernández de Sevilla A
Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716
[No Abstract] [Full Text] [Related]
2. Patient with high-grade fever, night sweats, and hepatosplenomegaly.
Müldür E; Chott A; Mirzaei S; Zojer N; Ludwig H
J Clin Oncol; 2011 Apr; 29(10):e254-6. PubMed ID: 21220615
[No Abstract] [Full Text] [Related]
3. Diagnosis of a primary cardiac B-cell lymphoma.
Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
[No Abstract] [Full Text] [Related]
4. Intravascular large B-cell lymphoma--a diagnostic dilemma.
Ramkumar B; Hutchison R; Khadim H; Gajra A
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e18-21. PubMed ID: 24060286
[No Abstract] [Full Text] [Related]
5. Tandem triplication of the BCL2 gene in CD5-positive intravascular large B cell lymphoma with bone marrow involvement.
Yamamoto K; Okamura A; Yakushijin K; Hayashi Y; Matsuoka H; Minami H
Ann Hematol; 2014 Oct; 93(10):1791-3. PubMed ID: 24577512
[No Abstract] [Full Text] [Related]
6. An 82-year-old woman with left upper lobe atelectasis. Diffuse large B-cell lymphoma.
Seeram V; Shujaat A; Jones L; Bajwa A
Chest; 2012 Dec; 142(6):1669-1674. PubMed ID: 23208341
[No Abstract] [Full Text] [Related]
7. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
8. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
9. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
Masaki Y; Miki M; Sakai T; Sawaki T; Fukushima T; Umehara H
Brain Nerve; 2011 May; 63(5):435-41. PubMed ID: 21515922
[TBL] [Abstract][Full Text] [Related]
10. [Asian variant of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy].
Tadokoro J; Arai Y; Tokita K; Iso H; Nakamura Y; Maki K; Sasaki K; Mitani K
Rinsho Ketsueki; 2007 Jan; 48(1):61-3. PubMed ID: 17313078
[TBL] [Abstract][Full Text] [Related]
11. Intravascular large B cell lymphoma: widespread but not everywhere.
Ponzoni M; Ferreri AJ
Acta Haematol; 2014; 131(1):16-7. PubMed ID: 24021531
[No Abstract] [Full Text] [Related]
12. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
[No Abstract] [Full Text] [Related]
13. Large B-cell non-Hodgkin lymphoma.
Vaseemuddin M; Sam R
Am J Kidney Dis; 2005 Dec; 46(6):A52, e101-2. PubMed ID: 16315353
[No Abstract] [Full Text] [Related]
14. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
[TBL] [Abstract][Full Text] [Related]
16. Modified chop-chemotherapy plus rituximab for diffuse large b-cell lymphoma complicating ataxia-telangiectasia.
Rossi G; Zecca M; Marchi A; de Stefano P; Sammarchi L; Locatelli F
Br J Haematol; 2003 Jan; 120(2):369-71. PubMed ID: 12542504
[No Abstract] [Full Text] [Related]
17. Influence of rituximab-CHOP therapy on clinical course and autoimmune parameters in rheumatoid arthritis associated with diffuse large B cell non-Hodgkin lymphoma.
Vujasinovic-Stupar N; Pejnovic N; Markovic O; Babic G
Ann Hematol; 2008 Sep; 87(9):767-9. PubMed ID: 18386008
[No Abstract] [Full Text] [Related]
18. [Neurological disturbances caused by intravascular lymphomatosis].
Mizutani T
Brain Nerve; 2011 May; 63(5):443-9. PubMed ID: 21515923
[TBL] [Abstract][Full Text] [Related]
19. [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].
Kado H; Hatta T; Ueno R; Takagi A; Segawa H; Sawada K; Hosokawa Y
Nihon Jinzo Gakkai Shi; 2011; 53(7):1046-52. PubMed ID: 22073871
[TBL] [Abstract][Full Text] [Related]
20. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
